Medaphor Group PLC Notice of AGM (8149L)

TIDMMED

RNS Number : 8149L

Medaphor Group PLC

24 April 2018

24 April 2018

MedaPhor Group plc

("MedaPhor" or the "Group" or the "Company")

Notice of Annual General Meeting

MedaPhor Group plc (AIM: MED), the intelligent ultrasound software and simulation company, announces that the Company's Annual General Meeting ("the AGM") will be held will be held at IP Group Offices, The Walbrook Building, 25 Walbrook, London, EC4N 8AF on 17 May 2018 at 10.30am.

The Group's 2017 Annual Report which contains the formal notice of the AGM has today been posted on the Group's website, www.medaphor.com. Hard copies of the Annual Report including the Notice and a form of proxy for use at the AGM have been posted to all shareholders.

Medaphor is committed to reducing paper and improving efficiency in its shareholder communications. From 2019, the Company will no longer be sending paper proxy cards to shareholders unless specifically asked to do so. Advice on how to request a paper proxy will be provided to shareholders at the appropriate time.

A copy of this announcement is available on the Group's website: www.medaphor.com

Enquiries:

 
 MedaPhor Group plc                             www.medaphor.com 
 Stuart Gall, CEO                            Tel: [phone] 
  Ian Whittaker, COO                                        6534 
 
 Cenkos Securities                           Tel: [phone] 
                                                            8900 
 Camilla Hume/Bobbie Hilliam 
  (Nominated Advisor) 
 Michael Johnson / Julian 
  Morse (Corporate Broking) 
 
 Walbrook PR                         Tel: [phone] or 
                                         [e-mail] 
 Paul McManus / Anna             Mob: [phone] / Mob: 
  Dunphy                                     [phone] 
 
 

About MedaPhor (www.investors.medaphor.com)

MedaPhor (AIM: MED), the intelligent ultrasound software and simulation company, develops artificial intelligence-based clinical image analysis software tools, augmented reality-based needle guidance software and advanced hi-fidelity haptic and manikin-based training simulators for medical practitioners.

Based in Cardiff and Oxford in the UK and Atlanta in the US and Hong Kong in Asia, MedaPhor operates two divisions:

Intelligent Ultrasound Simulation Division

Focuses on hi-fidelity ultrasound education and training through simulation. Its three main products are the ScanTrainer OBGYN and General Medical simulator training platform, the HeartWorks echocardiography simulator platform and the BodyWorks Eve Point of Care and Emergency Medicine Simulator. Over 500 MedaPhor simulators have been sold to over 300 medical institutions in over 30 countries around the world.

Intelligent Ultrasound Clinical Division

Focuses on augmented reality and deep-learning based algorithms to make ultrasound machines smarter and more accessible. Products in development include ScanNav which uses machine-learning based algorithms to automatically identify and grade ultrasound images to provide scan assessment and audit of obstetric scanning. NeedleGuide aims to simplify ultrasound-guided needling by using deep learning and augmented reality to provide the user with pathway guidance and automated tracking for a range of medical procedures.

Some products in the pipeline may require US FDA approval, as such this material should be considered informational only and does not constitute an offer to sell or infer claims or benefits.

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOAUOOORWVASUAR

(END) Dow Jones Newswires

April 24, 2018 02:01 ET (06:01 GMT)